cyclohexanol has been researched along with Diabetes Mellitus in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersohn, F; Garbe, E; Schade, R; Suissa, S | 1 |
| Crystal, S; Olfson, M; Sambamoorthi, U; Walkup, JT | 1 |
| Arguisola, MS; Tavakoli, SA | 1 |
| Ikeda, H; Odaka, H | 1 |
| Hayaishi, R; Imano, E; Kanda, T; Wada, M | 1 |
| Alberti, KG; Noy, GA; Sherif, IT; Walton, RJ | 1 |
| Sachse, G; Willms, B | 1 |
| Doi, K | 1 |
2 trial(s) available for cyclohexanol and Diabetes Mellitus
| Article | Year |
|---|---|
Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Cyclohexanols; Diabetes Mellitus; Female; Food; Glucosidases; Glycoside Hydrolase Inhibitors; Humans; Insulin; Lactates; Male; Middle Aged; Oligosaccharides; Pyruvates; Trisaccharides | 1979 |
Effect of the alpha-glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics.
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Cyclohexanols; Diabetes Mellitus; Female; Glucosidases; Glycoside Hydrolase Inhibitors; Humans; Insulin; Male; Middle Aged; Oligosaccharides; Sulfonylurea Compounds; Trisaccharides | 1979 |
6 other study(ies) available for cyclohexanol and Diabetes Mellitus
| Article | Year |
|---|---|
Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Body Mass Index; Case-Control Studies; Cyclohexanols; Depressive Disorder; Diabetes Mellitus; Female; Fluvoxamine; Humans; Incidence; Male; Middle Aged; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Time Factors; United Kingdom; Venlafaxine Hydrochloride | 2009 |
Diffusion of new generation antidepressant treatment among elderly diagnosed with depression.
Topics: Age Factors; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depression; Diabetes Mellitus; Fee-for-Service Plans; Female; Health Status; Heart Diseases; Humans; Hypertension; Male; Medicare; Monoamine Oxidase Inhibitors; Multivariate Analysis; Racial Groups; Sample Size; Sampling Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Socioeconomic Factors; Venlafaxine Hydrochloride | 2003 |
Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Interactions; Drug Therapy, Combination; Humans; Male; Obesity; Olanzapine; Pirenzepine; Risk Factors; Valproic Acid; Venlafaxine Hydrochloride | 2003 |
AO-128, alpha-glucosidase inhibitor: antiobesity and antidiabetic actions in genetically obese-diabetic rats, Wistar fatty.
Topics: Animals; Body Weight; Cyclohexanols; Diabetes Mellitus; Eating; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Male; Obesity; Rats; Rats, Wistar | 1995 |
[Occurrence of ileus after voglibose treatment in an elderly diabetic patient with gait disturbance caused by cerebral hemorrhage].
Topics: Cerebral Hemorrhage; Cyclohexanols; Diabetes Mellitus; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Gait; Glycoside Hydrolase Inhibitors; Humans; Intestinal Obstruction; Middle Aged; Obesity | 1996 |
[New oral antidiabetic agents].
Topics: Animals; Cyclohexanols; Diabetes Mellitus; Drug Evaluation; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Secretion; Molecular Structure; Pyrrolidines; Stimulation, Chemical; Sulfonylurea Compounds | 1990 |